Your browser doesn't support javascript.
loading
Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study.
Samajdar, Shambo Samrat; Mukherjee, Shatavisa; Moitra, Saibal; Pal, Jyotirmoy; Joshi, Shashank; Tripathi, Santanu Kumar.
Afiliação
  • Samajdar SS; Consultant at Diabetes and Allergy-Asthma Specialty Clinic, Kolkata & Clinical Pharmacologist at School of Tropical Medicine, Kolkata, West Bengal, India.
  • Mukherjee S; Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, West Bengal, India.
  • Moitra S; Department of Respiratory Medicine, Division of Allergy and Immunology, Apollo Multispeciality Hospital, Kolkata, West Bengal, India.
  • Pal J; Department of Medicine, R G Kar Medical College and Hospital, Kolkata, West Bengal, India.
  • Joshi S; Department of Diabetology and Endocrinology, Joshi Clinic, Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India.
  • Tripathi SK; Department of Pharmacology, Netaji Subhas Medical College and Hospital, Patna, Bihar, India.
Lung India ; 40(2): 107-111, 2023.
Article em En | MEDLINE | ID: mdl-37006092
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article